Trial intelligence / Profile preview

Butorphanol Sedation in Orthopedic Surgery

NCT03810391Phase 2Completed

Sponsor
Shengjing Hospital of China Medical University
Start
Dec 2017
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of butorphanol in Procedural sedation (PS) (4 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoints: Amsterdam Preoperative Anxiety and Information Scale, Ramsay Sedation Scale and 1 more. Started Dec 2017; status: completed.

02

Drugs

butorphanol
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT03810391.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03810391.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call